There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Align Tech (ALGN), IQVIA Holdings (IQV) and Hologic (HOLX) with bullish sentiments.
Align Tech (ALGN)
In a report released today, Richard Newitter from Leerink Partners maintained a Buy rating on Align Tech, with a price target of $340.00. The company’s shares closed last Wednesday at $317.97, close to its 52-week high of $326.36.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of 23.1% and a 68.3% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Intuitive Surgical.
Currently, the analyst consensus on Align Tech is a Moderate Buy with an average price target of $310.71, a -1.5% downside from current levels. In a report issued on July 17, Stifel Nicolaus also maintained a Buy rating on the stock with a $350.00 price target.
See today’s analyst top recommended stocks >>
IQVIA Holdings (IQV)
In a report released today, Ricky Goldwasser from Morgan Stanley maintained a Buy rating on IQVIA Holdings, with a price target of $182.00. The company’s shares closed last Wednesday at $164.29, close to its 52-week high of $169.14.
According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 16.3% and a 68.4% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Quest Diagnostics, and 1Life Healthcare.
IQVIA Holdings has an analyst consensus of Strong Buy, with a price target consensus of $177.00, which is a 12.8% upside from current levels. In a report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a $201.00 price target.
Hologic (HOLX)
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Hologic, with a price target of $68.00. The company’s shares closed last Wednesday at $62.17, close to its 52-week high of $62.69.
According to TipRanks.com, Bedford is a 5-star analyst with an average return of 16.2% and a 70.6% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, Edwards Lifesciences, and Tandem Diabetes Care.
Currently, the analyst consensus on Hologic is a Strong Buy with an average price target of $63.13, which is a 2.1% upside from current levels. In a report issued on July 15, Leerink Partners also maintained a Buy rating on the stock with a $66.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
